130 related articles for article (PubMed ID: 16766585)
1. Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial.
Jäger G; Neumeister P; Quehenberger F; Wöhrer S; Linkesch W; Raderer M
Ann Oncol; 2006 Nov; 17(11):1722-3. PubMed ID: 16766585
[No Abstract] [Full Text] [Related]
2. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.
Jäger G; Neumeister P; Brezinschek R; Hinterleitner T; Fiebiger W; Penz M; Neumann HJ; Mlineritsch B; DeSantis M; Quehenberger F; Chott A; Beham-Schmid C; Höfler G; Linkesch W; Raderer M
J Clin Oncol; 2002 Sep; 20(18):3872-7. PubMed ID: 12228207
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety and activity of cladribine in patients with extranodal B-cell marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma.
Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME; Raderer M
Hematol Oncol; 2017 Jun; 35(2):177-186. PubMed ID: 26580149
[TBL] [Abstract][Full Text] [Related]
4. Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.
Troch M; Kiesewetter B; Willenbacher W; Willenbacher E; Zebisch A; Linkesch W; Fridrik M; Müllauer L; Greil R; Raderer M
Haematologica; 2013 Feb; 98(2):264-8. PubMed ID: 22983582
[TBL] [Abstract][Full Text] [Related]
5. Complete remission of chronic plaque psoriasis and gastric marginal zone B-cell lymphoma of MALT type after treatment with 2-chlorodeoxyadenosine.
Valencak J; Trautinger F; Fiebiger WC; Raderer M
Ann Hematol; 2002 Nov; 81(11):662-5. PubMed ID: 12454707
[TBL] [Abstract][Full Text] [Related]
6. Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.
Conconi A; Raderer M; Franceschetti S; Devizzi L; Ferreri AJ; Magagnoli M; Arcaini L; Zinzani PL; Martinelli G; Vitolo U; Kiesewetter B; Porro E; Stathis A; Gaidano G; Cavalli F; Zucca E
Br J Haematol; 2014 Jul; 166(1):69-76. PubMed ID: 24673512
[TBL] [Abstract][Full Text] [Related]
7. T(11;18)-bearing pulmonary mucosa-associated lymphoid tissue lymphoma responding to cladribine.
Kusumoto S; Kobayashi Y; Tanimoto TE; Hasegawa T; Yokota Y; Tanimoto K; Sekiguchi N; Narabayashi M; Watanabe T; Matsuno Y; Tobinai K
Int J Hematol; 2004 Jul; 80(1):70-4. PubMed ID: 15293572
[TBL] [Abstract][Full Text] [Related]
8. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
[TBL] [Abstract][Full Text] [Related]
9. 2-Chlorodeoxyadenosine, a "novel" agent in the treatment of both lymphoid and myeloid malignancies.
Lauria F
Haematologica; 1992; 77(6):443-5. PubMed ID: 1363233
[No Abstract] [Full Text] [Related]
10. Experience with clarithromycin as antineoplastic therapy for extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT-lymphoma) outside of clinical trials: Real-world data from the University of Vienna.
Pokorny A; Kiesewetter B; Raderer M
Hematol Oncol; 2020 Aug; 38(3):409-411. PubMed ID: 32347560
[No Abstract] [Full Text] [Related]
11. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma.
Beksaç M; Arat M; Idilman R
Cancer; 1999 Jan; 85(1):242-3. PubMed ID: 9921999
[No Abstract] [Full Text] [Related]
12. Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma.
Nagai H; Ogura M; Kusumoto S; Takahashi N; Yamaguchi M; Takayama N; Kinoshita T; Motoji T; Ohyashiki K; Kosugi H; Matsuda S; Ohnishi K; Omachi K; Hotta T
Eur J Haematol; 2011 Feb; 86(2):117-23. PubMed ID: 21070370
[TBL] [Abstract][Full Text] [Related]
13. Edema of the eyelids and sclera after rituximab infusion for orbital MALT lymphoma.
Oribe N; Tanimoto TE; Shimoda K; Hikiji W; Mitsugi K; Takase K; Henzan H; Numata A; Miyamoto T; Fukuda T; Nagafuji K; Harada M
Haematologica; 2004 Jun; 89(6 Suppl):EIM14. PubMed ID: 15194556
[No Abstract] [Full Text] [Related]
14. Purine analogs in marginal-zone lymphomas.
Horning SJ
Ann Oncol; 1996; 7 Suppl 6():S21-6. PubMed ID: 9010575
[TBL] [Abstract][Full Text] [Related]
15. [Cladribine monotherapy for patients with relapsed or refractory indolent non-Hodgkin lymphoma].
Nakashima Y; Shimada T; Yamada Y; Choi I; Yufu Y; Uike N
Rinsho Ketsueki; 2004 Jul; 45(7):568-70. PubMed ID: 15359918
[TBL] [Abstract][Full Text] [Related]
16. 2-Chlorodeoxyadenosine as first-line treatment in bronchus-associated lymphoid tissue lymphoma.
Neumeister P; Linkesch W; Höfler G; Sill H
Blood; 1996 Apr; 87(8):3526. PubMed ID: 8605379
[No Abstract] [Full Text] [Related]
17. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.
Raderer M; Jäger G; Brugger S; Püspök A; Fiebiger W; Drach J; Wotherspoon A; Chott A
Oncology; 2003; 65(4):306-10. PubMed ID: 14707449
[TBL] [Abstract][Full Text] [Related]
18. Treatment of indolent non-Hodgkin's lymphoma with cladribine as single-agent therapy and in combination with mitoxantrone.
Armitage JO; Tobinai K; Hoelzer D; Rummel MJ
Int J Hematol; 2004 May; 79(4):311-21. PubMed ID: 15218957
[TBL] [Abstract][Full Text] [Related]
19. CD5-negative mantle cell lymphoma resembling extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue : a case report.
Hashimoto Y; Omura H; Tanaka T; Hino N; Nakamoto S
J Clin Exp Hematop; 2012; 52(3):185-91. PubMed ID: 23269078
[TBL] [Abstract][Full Text] [Related]
20. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP).
Wöhrer S; Drach J; Hejna M; Scheithauer W; Dirisamer A; Püspök A; Chott A; Raderer M
Ann Oncol; 2003 Dec; 14(12):1758-61. PubMed ID: 14630681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
